PQ Gasil® Silica Excipient General Brochure 2026
Highlighting the PQ portfolio of silica excipients for use in pharmaceutical and nutraceutical applications. Key application areas:• Physical and chemical moisture
protection
• MADG (Moisture Activated Dry Granulation)
• API and liquid carrying
• Glidant functionality to improve flow behavior
• Tableting and processing support
PQ Corporation
-
Country/Region:United States
-
Founded:1815
-
On CPHI since:2026
-
Employees:1000 - 4999
Other Content from PQ Corporation (3)
-
News Excipient supplier PQ on PharmaExcipients platform
Reach out to PQ via PharmaExcipients.com for all your silica excipients needs. Technical literature available demonstrating the performance of PQ silicas against industry incumbents. -
Brochure Gasil® Mesoporous Silica as a Glidant for Powder Flow and Tableting
Gasil® mesoporous silica grades HP33CP and HP54CP improve flow performance in microcrystalline cellulose formulations and reduced tablet weight variability. -
News GASIL® Mesoporous Silicas – Elevating Pharmaceutical and Nutraceutical Excellence
Gasil® mesoporous silica gels address the core formulation challenges in pharmaceuticals and nutraceuticals — moisture sensitivity, liquid-to-powder conversion and dosing accuracy, poor powder flow for tableting, and low API solubility requiring amorphization.